Plain-English translation of NCT07109141 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is building a nationwide registry of patients receiving pulsed field ablation (PFA), a newer technique for treating irregular heartbeats in the upper chambers of the heart. PFA works by using electrical pulses to carefully damage only the heart muscle cells that are causing the arrhythmia, leaving surrounding tissue unharmed. Researchers want to collect information about how well this treatment works for different types of heart rhythm problems and whether it is safe.
Pulsed field ablation has shown promise for treating a common arrhythmia called atrial fibrillation, but doctors are increasingly using it to treat other types of irregular heartbeats as well. This study exists to systematically document whether the treatment is effective and safe for these other arrhythmias, and to gather information that will help design larger research studies in the future.
You likely qualify if…
You likely don't qualify if…
If you join, you will receive the ablation procedure as part of your normal clinical care—the study does not require any additional procedures during your hospital stay. After you go home, you will receive follow-up telephone calls at 3 months, 6 months, and 12 months after your procedure to check on your progress. If the research team has concerns based on those phone calls, you may be invited back to the hospital for an in-person visit to make sure everything is going well.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
Poland